Cytokines in serum, nasal secretion and exhaled breath condensate during mepolizumab therapy in patients with different phenotypes of severe eosinophilic asthma: A pilot study

Clin Exp Allergy. 2022 Dec;52(12):1444-1447. doi: 10.1111/cea.14231. Epub 2022 Sep 21.

Authors

Alicja Nowak-Jurek¹, Adrian Gajewski¹, Karolina Frachowicz-Guereirro¹, Monika Antczak-Marczak¹, Izabela Gulbas¹, Marek Leszek Kowalski¹, Maciej Chałubiński¹, Aleksandra Wardzyńska¹

Affiliation

¹ Department of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.

PMID: 36106662
DOI: 10.1111/cea.14231

No abstract available

Publication types

Letter

MeSH terms

Anti-Asthmatic Agents* / adverse effects
Asthma* / diagnosis
Asthma* / drug therapy
Breath Tests
Cytokines
Humans
Pilot Projects

Substances

Cytokines
Anti-Asthmatic Agents